Insights into innovation investment from venture capitalist Dr Chris Smith

In the latest episode of Med Tech Talks, Robert Klupacs is joined by Dr Chris Smith, a partner at Brandon Capital - Australasia's leading life science venture capital firm. Chris has extensive experience in the global biotech industry. With a PhD in immunology and an MBA specialising in innovation and entrepreneurship from the University of Cambridge; he has also previously been a business development manager with CSL; and is currently a Director of Aravax, Denteric, Ena Respiratory, MycRx, Q-Sera and Axelia Oncology, just to name a few. In this episode, you will hear more about: Tips for pitching to investors and building a relationship with venture capital firms Demystifying the role of a VC in research and development Brandon Capital’s incubator approach to risk and investing in early-stage innovations. Learn about Dr Chris Smith Visit the Brandon Capital website Updated version 05/08/22